摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

methyl (6S,9R,14R)-14-((S)-2-((tert-butoxycarbonyl)amino)propanamido)-9-(methoxycarbonyl)-2,2,6-trimethyl-4,7-dioxo-3-oxa-11,12-dithia-5,8-diazapentadecan-15-oate | 55300-75-9

中文名称
——
中文别名
——
英文名称
methyl (6S,9R,14R)-14-((S)-2-((tert-butoxycarbonyl)amino)propanamido)-9-(methoxycarbonyl)-2,2,6-trimethyl-4,7-dioxo-3-oxa-11,12-dithia-5,8-diazapentadecan-15-oate
英文别名
Ala-Cystine-OMe;Boc-Ala-Cys(1)-OMe.Boc-Ala-Cys(1)-OMe;methyl (2R)-3-[[(2R)-3-methoxy-2-[[(2S)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoyl]amino]-3-oxopropyl]disulfanyl]-2-[[(2S)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoyl]amino]propanoate
methyl (6S,9R,14R)-14-((S)-2-((tert-butoxycarbonyl)amino)propanamido)-9-(methoxycarbonyl)-2,2,6-trimethyl-4,7-dioxo-3-oxa-11,12-dithia-5,8-diazapentadecan-15-oate化学式
CAS
55300-75-9
化学式
C24H42N4O10S2
mdl
——
分子量
610.75
InChiKey
GZTYIOJEJFDWLS-VGWMRTNUSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.7
  • 重原子数:
    40
  • 可旋转键数:
    19
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.75
  • 拓扑面积:
    238
  • 氢给体数:
    4
  • 氢受体数:
    12

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Synthesis Of A New Series Of Cyclic Pseudopeptides Containing Pyridine As Backbone Modifier
    作者:Hai Huang、Lin-Jing Mu、Jin-Pei Cheng、Jian-Ming Lu、Xu-Bo Hu
    DOI:10.1080/00397919808004529
    日期:1998.12
    Abstract A new class of cyclic pseudo-peptides which contains pyridine and cystine in the backbone structure was synthesized by a simple three-step preparation. The structures of products were characterized by spectroscopic and conventional analytical methods.
    摘要 通过简单的三步制备方法合成了一类新的主链结构中含有吡啶和胱酸的环状假肽。通过光谱和常规分析方法对产物的结构进行表征。
  • Ferrocenyl-Bearing Cyclopseudopeptides as Redox-Switchable Cation Receptors
    作者:Hai Huang、Linjing Mu、Jiaqi He、Jin-Pei Cheng
    DOI:10.1021/jo030105v
    日期:2003.10.1
    A family of ferrocenyl-bearing cyclopseudopeptides (1-10) designed for redox-switchable receptors of cations was synthesized. Circular dichroism (CD) and cyclic valtammetry (CV) studies of cation binding properties in both the reduced (K-1) and oxidized (K-2) forms revealed that the binding preference is mainly governed by the charges and radius of the guest cation as well as by the suitability of the host to accommodate the guest. Particularly worth mentioning is the fact that some synthesized cyclopseudopeptides showed high binding affinity and selectivity toward alkaline-earth ions. For example, the K-1 of compound 2 binding with Ca2+ is 4.37 x 10(6) mol(-1).L and its Ca2+/K+ selectivity is 3.1 x 10(1):1, both values are much greater than those of an excellent natural ionophore, valinomycin (1 x 10(5) mol(-1).L and 0.33:1, respectively). The linear relationship between the shifts of half-wave potentials (DeltaE(1/2)) and the radius/charge [r/(+)] ratios suggests that the sensitivity of electrochemical responses to cation complexation be dominated by repulsion factors between the redox center and the incoming cation guest.
  • New diastereoselective synthesis of protected meso-lanthionine with discrimination of the chiral centers
    作者:Florine Cavelier-Frontin、Jacques Daunis、Robert Jacquier
    DOI:10.1016/s0957-4166(00)82315-0
    日期:1992.1
    A synthesis of meso-lanthionine with discrimination of the chiral centers is reported. Two cysteine residues of opposite configuration and with orthogonal protections are temporarily and reversibly linked in order to promote the formation of an intramolecular disulfide bridge thus avoiding symmetrization reactions during the sulfur extrusion step.
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸